During the past decade, Okanagan Clinical Trials conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 12 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 10 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Okanagan Clinical Trials" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "TauRx Therapeutics Ltd" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Okanagan Clinical Trials" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Banner Alzheimer's Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Okanagan Clinical Trials" are "Alzheimer Disease" (6 trials), "Alzheimer's Disease" (4 trials), "Crohn Disease" (3 trials), "Alzheimers Disease" (2 trials) and "Bipolar Depression" (2 trials). Many other conditions were trialed in "Okanagan Clinical Trials" in a lesser frequency.

Most popular intervention types in "Okanagan Clinical Trials" are "Drug" (34 trials), "Other" (5 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Ozanimod" (3 trials), "Aticaprant" (2 trials), "Lanabecestat" (2 trials) and "Lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Okanagan Clinical Trials" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Okanagan Clinical Trials". undefined are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Okanagan Clinical Trials, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Okanagan Clinical Trials, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".